Physician profile
Mark Browning
NPI 1629041199
$2,993.03
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,658 · 2023: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $1,918.00 | 2019 | |
| Celgene Corporation | $151.20 | 2019 | |
| Genzyme Corporation | $127.00 | 2019-2023 | |
| Pharmaessentia USA Corporation | $125.15 | 2023 | Besremi |
| Novartis Pharmaceuticals Corporation | $92.90 | 2019 | |
| Daiichi Sankyo INC. | $80.00 | 2023 | Enhertu |
| Incyte Corporation | $71.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $71.43 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $51.00 | 2019 | |
| Merck Sharp & Dohme LLC | $31.20 | 2019 | |
| Gilead Sciences, INC. | $28.38 | 2019 | |
| Eisai INC. | $27.72 | 2019 | |
| Tesaro, INC. | $27.25 | 2019 | |
| Seagen INC. | $26.47 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.95 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beigene USA, INC. | $18.21 | 2023 | Brukinsa |
| Lilly USA, LLC | $17.87 | 2019 | |
| Rigel Pharmaceuticals, INC. | $15.99 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $14.24 | 2019 | |
| Astellas Pharma US INC | $14.02 | 2019 | |
| Genentech USA, INC. | $12.31 | 2019 | |
| Janssen Biotech, INC. | $11.94 | 2019 | |
| Puma Biotechnology, INC. | $11.59 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.17 | 2019 | |
| Pfizer INC. | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Browning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.